US equities
|
SPCX
$167.07
▲+5.11%
NVDA
$237.07
▲+1.34%
MU
$1,065.83
▼-0.84%
TSLA
$375.62
▲+1.36%
MSFT
$526.31
▲+1.70%
INTC
$117.08
▼-1.89%
SNDK
$1,720.41
▲+0.02%
META
$743.41
▲+2.11%
SPCX
$167.07
▲+5.11%
NVDA
$237.07
▲+1.34%
MU
$1,065.83
▼-0.84%
TSLA
$375.62
▲+1.36%
MSFT
$526.31
▲+1.70%
INTC
$117.08
▼-1.89%
SNDK
$1,720.41
▲+0.02%
META
$743.41
▲+2.11%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Dimensional World ex U.S. Core Equity 2 ETF
(NY:
DFAX
)
37.37
+0.09 (+0.24%)
Delayed Quote
Updated: 10:48 AM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Dimensional World ex U.S. Core Equity 2 ETF
< Previous
1
2
3
Next >
Stellantis Recalls Nearly 54,000 Vehicles In US Over Concerns Regarding Fuel Pump: But Retail Sees Stock Rallying To $10 This Week
↗
September 16, 2025
Via
Stocktwits
Topics
Product Recall
Eli Lilly, Novo Nordisk Preparing To Introduce Obesity Pills Next Year In The US: Report
↗
September 12, 2025
Via
Stocktwits
Toyota Recalls Over Half A Million Vehicles In The US
↗
September 11, 2025
Via
Stocktwits
Topics
Product Recall
Ford Supplier Magna International Appoints Former Timken Executive As CFO
↗
September 11, 2025
Via
Stocktwits
Topics
Supply Chain
Stellantis Stock Slips After US Regulator Probes 287,000 Chrysler Minivans Over Concerns Regarding Electric Power Steer
↗
September 08, 2025
Via
Stocktwits
Sanofi’s New Experimental Eczema Drug Meets Goals Of Late-stage Trial, But Wall Street Expected More
↗
September 04, 2025
Via
Stocktwits
Citi Lowers Price Target On This Chinese EV Maker After Disappointing Q3 Guidance: Retail Expects Shares To ‘Eventually Implode’
↗
August 29, 2025
Via
Stocktwits
This Pharma Stock Is Down 19% In 2025 But Just Received An ‘Explosive News’ – Find Out More
↗
August 28, 2025
Via
Stocktwits
Stellantis Shells Out $41M More To Expand Its U.S. Parts Distribution Network: More Details Inside
↗
August 27, 2025
Via
Stocktwits
This Stock Just Got Downgraded By Macquarie On Rising Competition In Chinese Market – Do You Own It?
↗
August 22, 2025
Via
Stocktwits
Health Canada Approves Novo’s Ozempic to Reduce Risk Of Kidney Function Decline, Cardiovascular Death
↗
August 19, 2025
Via
Stocktwits
Li Auto Announces Lower Q3 Delivery Outlook Despite New Vehicle Launches: Retail Sees i8, i6 Selling Like ‘Hot Cakes’
↗
August 28, 2025
Li Auto now expects vehicle deliveries to be between 90,000 and 95,000 vehicles, representing a year-over-year decrease of 41.1% to 37.8%.
Via
Stocktwits
Topics
Earnings
This Pharma Major’s Stock Has Lost 59% Of Its Value In A Year – Why Is It Drawing Investor Interest Today?
↗
August 28, 2025
Novo Nordisk has entered into a collaboration with Replicate BioScience under which it will receive a defined, exclusive, worldwide license to use the latter’s self-replicating RNA platform to develop...
Via
Stocktwits
OraSure Receives Warning From Ron Zwanziger: Entrepreneur Warns Of Adversarial Path If Board Continues To Refuse Buyout Offer
↗
August 25, 2025
Zwanziger made an unsolicited all-cash offer for the company earlier in the summer but was rebuffed.
Via
Stocktwits
Novo Nordisk Freezes Hiring To Cut Costs, Says Report: Retail Sees Stock Surpassing $100-Mark In A Year
↗
August 20, 2025
Novo’s website currently shows multiple job openings in the U.S. and mainland China, but merely eight open positions in Denmark.
Via
Stocktwits
Toyota Warns Higher US Tariff Impact For FY26: Retail Sees No Reason To Cheer
↗
August 07, 2025
Via
Stocktwits
US FDA Reviewers Highlight Safety Concerns With GSK’s Investigational Cancer Drug: Retail’s On The Fence
↗
July 15, 2025
Via
Stocktwits
AstraZeneca Stock Rises As Experimental Drug Lowers Blood Pressure In Late-Stage Study, Retail’s Yet To React
↗
July 14, 2025
Via
Stocktwits
Novartis Fails To Block Heart Failure Drug’s Generic From Launching Through 2026: Report
↗
July 11, 2025
Via
Stocktwits
AstraZeneca Launches Home Delivery Service For Its Self-Administrable Flu Vaccine
↗
August 15, 2025
Flumist can be self-administered by adults 18 to 49 years of age or administered by a parent or caregiver to individuals 2-17 years of age.
Via
Stocktwits
Philips Plans $150M New Investments In US Manufacturing, R&D: Retail’s On The Fence
↗
August 14, 2025
The investment includes the expansion of the company’s Reedsville, PA, site and the recently announced expansion of the Image Guided Therapy facility in Plymouth, MN, the company said.
Via
Stocktwits
Topics
Economy
Government
Novo Nordisk Downgraded By UBS Over Uncertain Outlook For Wegovy, But Retail Prefers To Look At The Sunny Side
↗
August 05, 2025
UBS downgraded Novo Nordisk to ‘Neutral’ from ‘Buy’ with a price target of DKK 340, down from DKK 600.
Via
Stocktwits
Stellantis Just Made A Fresh Appointment To Its North American Design Division: More Details Inside
↗
July 31, 2025
Kruger’s position was newly created, and he will report to CEO Antonio Filosa.
Via
Stocktwits
Topics
World Trade
Novo Nordisk Hit With Stock Downgrades After Lowering Full-Year Outlook: But Retail Is Optimistic On Company’s Profitability
↗
July 30, 2025
Barclays downgraded Novo to ‘Equal Weight’ from ‘Overweight’ with a price target of DKK 375, down from DKK 700.
Via
Stocktwits
GSK Expects Full-Year Earnings At Top End Of Guidance: CEO Says ‘Confident In Our Long-Term Outlooks’
↗
July 30, 2025
GSK now expects turnover growth to be toward the top end of 3% to 5% and core earnings per share growth to be closer to 8% at constant exchange rate.
Via
Stocktwits
Topics
Artificial Intelligence
World Trade
Novo Nordisk Stock Slumps After Slashing Full-Year Guidance, But Retail Has Its Eyes On An Oral Weight Loss Drug
↗
July 29, 2025
The company now expects full-year sales growth of 8% to 14% at a constant exchange rate, down from its previous estimate of 13% to 21%.
Via
Stocktwits
GSK Seeks FDA Approval For RSV Vaccine In More Adults: Retail Sees No Reason To Shift Their Bullish Stance
↗
July 14, 2025
A decision by the FDA on the new submission is expected in the first half of 2026.
Via
Stocktwits
Novo Nordisk Seeks Approval For Higher Wegovy Dose In Europe
↗
July 08, 2025
In addition to the submission to the EMA, Novo Nordisk aims to make the higher dose of Wegovy widely available throughout the European Union.
Via
Stocktwits
Novartis Gets Swiss Authority Nod For First Malaria Drug In Newborns, Young Infants
↗
July 08, 2025
The company said that it now expects rapid approval for the treatment in eight African countries, including Burkina Faso, Côte d'Ivoire, Kenya, Malawi, Mozambique, Nigeria, Uganda, and Tanzania.
Via
Stocktwits
Topics
Death
Government
Stellantis Production In Italy Slumps 27% In H1 2025: Union Now Expects Slump In Annual Numbers
↗
July 07, 2025
The union expects the carmaker to produce 440,000 vehicles across its six assembly plants in Italy this year, including 250,000 passenger cars.
Via
Stocktwits
< Previous
1
2
3
Next >
